JP2005517653A5 - - Google Patents

Download PDF

Info

Publication number
JP2005517653A5
JP2005517653A5 JP2003552268A JP2003552268A JP2005517653A5 JP 2005517653 A5 JP2005517653 A5 JP 2005517653A5 JP 2003552268 A JP2003552268 A JP 2003552268A JP 2003552268 A JP2003552268 A JP 2003552268A JP 2005517653 A5 JP2005517653 A5 JP 2005517653A5
Authority
JP
Japan
Prior art keywords
pharmaceutically active
sustained release
implant
agent
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003552268A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005517653A (ja
Filing date
Publication date
Priority claimed from AUPR9515A external-priority patent/AUPR951501A0/en
Application filed filed Critical
Publication of JP2005517653A publication Critical patent/JP2005517653A/ja
Publication of JP2005517653A5 publication Critical patent/JP2005517653A5/ja
Withdrawn legal-status Critical Current

Links

JP2003552268A 2001-12-14 2002-12-09 X線不透過性徐放性医薬器具 Withdrawn JP2005517653A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR9515A AUPR951501A0 (en) 2001-12-14 2001-12-14 Modified sustained release pharmaceutical system
PCT/AU2002/001661 WO2003051335A1 (en) 2001-12-14 2002-12-09 Radioopaque sustained release pharmaceutical system

Publications (2)

Publication Number Publication Date
JP2005517653A JP2005517653A (ja) 2005-06-16
JP2005517653A5 true JP2005517653A5 (cg-RX-API-DMAC7.html) 2006-02-02

Family

ID=3833131

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003552268A Withdrawn JP2005517653A (ja) 2001-12-14 2002-12-09 X線不透過性徐放性医薬器具

Country Status (9)

Country Link
US (1) US20050063907A1 (cg-RX-API-DMAC7.html)
EP (1) EP1453482A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005517653A (cg-RX-API-DMAC7.html)
CN (1) CN1589133A (cg-RX-API-DMAC7.html)
AU (1) AUPR951501A0 (cg-RX-API-DMAC7.html)
BR (1) BR0214159A (cg-RX-API-DMAC7.html)
CA (1) CA2468986A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ532378A (cg-RX-API-DMAC7.html)
WO (1) WO2003051335A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
JP2006500115A (ja) 2000-11-16 2006-01-05 マイクロスフエリツクス・エル・エル・シー 密封小線源治療用の可撓性および/または弾性シードまたはストランド
CN1638747A (zh) * 2002-01-24 2005-07-13 斯玛特药物系统公司 持续释放药物组合物
US8920826B2 (en) * 2002-07-31 2014-12-30 Boston Scientific Scimed, Inc. Medical imaging reference devices
PL1696822T3 (pl) * 2003-11-13 2010-08-31 Psivida Inc Wstrzykiwane implanty o opóźnionym wydzielaniu mające matrycę rdzenia i powłokę podatne na erozję biologiczną
TWI434676B (zh) 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用x射線看出之藥物遞送裝置
DE102006021016A1 (de) * 2006-05-05 2007-11-15 Dürschinger, Günter Chemisch aktivierbare Kapsel für die Durchgangsprüfung und Behandlung des Darm-Trakts
US8475823B2 (en) * 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
US8956642B2 (en) * 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
US20100203102A1 (en) * 2009-02-10 2010-08-12 Warsaw Orthopedic, Inc. Compositions and methods for treating post-operative pain using bupivacaine and an anti-onflammatory agent
CN102355891A (zh) * 2009-03-17 2012-02-15 英特威国际有限公司 大环内酯药物递送系统
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate
WO2016204026A1 (ja) * 2015-06-15 2016-12-22 seven dreamers laboratories株式会社 鼻腔留置デバイス
US11096781B2 (en) 2016-08-01 2021-08-24 Edwards Lifesciences Corporation Prosthetic heart valve
WO2018067882A1 (en) 2016-10-05 2018-04-12 Titan Pharmaceuticals, Inc. Implantable devices for drug delivery with reduced burst release
CA3199943A1 (en) 2020-08-24 2022-03-03 Edwards Lifesciences Corporation Balloon cover for a delivery apparatus for an expandable prosthetic heart valve

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD205069A1 (de) * 1982-04-14 1983-12-21 Univ Ernst Moritz Arndt Verfahren zur herstellung eines therapeutischen mittels
US4866132A (en) * 1986-04-17 1989-09-12 The Research Foundation Of State University Of New York Novel radiopaque barium polymer complexes, compositions of matter and articles prepared therefrom
ES2038669T3 (es) * 1986-09-18 1993-08-01 London School Of Pharmacy Innovations Ltd Formulacion farmaceutica.
ATE108651T1 (de) * 1988-05-20 1994-08-15 Liposome Co Inc Aktives mittel: lipid-komplex mit hohem verhältnis.
GB9204918D0 (en) * 1992-03-06 1992-04-22 Nycomed As Chemical compounds
US5674468A (en) * 1992-03-06 1997-10-07 Nycomed Imaging As Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons
CZ284844B6 (cs) * 1992-03-06 1999-03-17 Nycomed Imaging A/S Kontrastní prostředek a způsob jeho výroby
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
CN1168640A (zh) * 1994-08-17 1997-12-24 波士顿科技公司 植入体、植入方法和施放装置
AU716005B2 (en) * 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
UA54505C2 (uk) * 1997-04-03 2003-03-17 Гілфорд Фармасьютікалз Інк. Полімери, що біологічно розкладаються, зшиті фосфатами, композиції, вироби і способи для їх виготовлення і використання
EP0938894A1 (en) * 1998-02-16 1999-09-01 Biomat B.V. Implantable radiopaque device and use thereof
IL133196A0 (en) * 1999-11-29 2001-03-19 Yissum Res Dev Co Gastroretentive controlled release pharmaceutical dosage forms
US6599448B1 (en) * 2000-05-10 2003-07-29 Hydromer, Inc. Radio-opaque polymeric compositions

Similar Documents

Publication Publication Date Title
JP4800570B2 (ja) 徐放性医薬組成物
JP4459444B2 (ja) 多層構造を有する放出制御製剤
JP2005505557A (ja) 持続放出医薬組成物の調製
JP4913321B2 (ja) 徐放性医薬組成物
JP2004535473A5 (cg-RX-API-DMAC7.html)
JP2013049705A (ja) 持続放出医薬組成物
DE2158226A1 (de) Arzneimittelwirkstofftraeger aus siliconkautschuk
JP2004530721A5 (cg-RX-API-DMAC7.html)
AU2009236413A1 (en) Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
DE60121355T2 (de) Absorptionsverbesserer
CN101616708A (zh) 鼻充血、鼻塞的减轻和药物的输送
AU2002344685A1 (en) Sustained release pharmaceutical composition
AU2005295112A1 (en) Biocompatible protein particles, particle devices and methods thereof
JP2005517653A (ja) X線不透過性徐放性医薬器具
JP2005522418A (ja) 徐放性医薬組成物
JPH05238929A (ja) 代謝性骨疾患治療用長期持続性製剤
JP2005505513A (ja) 寄生虫病の治療
ES2243311T3 (es) Formulaciones de medicamentos de liberacion prolongada para implantes.
AU2002315568B2 (en) Preparation of sustained release pharmaceutical composition
AU2002366248A2 (en) Radioopaque sustained release pharmaceutical system
AU2002315568A1 (en) Preparation of sustained release pharmaceutical composition
JP2001199879A (ja) 薬物放出製剤